Monday, Evolus, Inc. (EOLS) announced the pricing of the underwritten offering of 3,554,000 shares of its common stock at $14.07 per share, matching the closing price on Friday, March 8, 2024.
The company expects gross proceeds of approximately $50 million, excluding underwriting discounts, commissions, and other offering expenses.
Moreover, the underwriters have the option to purchase up to 533,100 additional shares at the offering price minus underwriting discounts and commissions within 30 days.
The company plans to use the net proceeds to support Jeuveau's growth, fund the launch of Evolysse, explore potential business development opportunities, and for general corporate purposes.
The offering is projected to close around March 13, 2024, pending customary closing conditions, with Leerink Partners and Stifel serving as joint book-running managers for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.